The FDA has urged Amsino International, Baxter Healthcare and seven other device companies to look at the rate of bloodstream infections that may be associated with the use of positive displacement needleless connectors, which are used in administering intravenous fluids. The agency's request comes after receiving reports of three bloodstream infection-linked deaths in patients who are using the devices.

Related Summaries